Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review

被引：2

作者：

Zhang, Yanjie ^{[1
]}

Pan, Juan ^{[2
]}

Kang, Haixin ^{[1
]}

Peng, Shuotao ^{[1
]}

Tung, Tao-Hsin ^{[3
]}

Shen, Bo ^{[1
]}

机构：

[1] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Clin Lab, Linhai, Peoples R China

[2] Zhejiang Univ, Taizhou Hosp, Dept Clin Lab, Linhai, Peoples R China

[3] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Evidence Based Med Ctr, Linhai, Peoples R China

来源：

ANNALS OF MEDICINE | 2024年 / 56卷 / 01期

关键词：

multiple myeloma; renal impairment; progression-free survival; overall survival; prognosis; STEM-CELL TRANSPLANTATION; ACUTE KIDNEY INJURY; SWOG S0777; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; MANAGEMENT; OUTCOMES; IMPACT; INTENT;

D O I：

10.1080/07853890.2024.2380301

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BackgroundMultiple myeloma is a malignant tumour of the blood in which abnormal proliferation of plasma cells leads to bone destruction, renal impairment, anaemia, and hypercalcaemia. Renal impairment caused by multiple myeloma is a common and serious condition; however, the prognosis of multiple myeloma at the time of diagnosis remains unclear.MethodWe conducted searches for literature in PubMed, Web of Science, Cochrane, Embase, CNKI, Wanfang, and VIP databases up to 30 April 2023. Progression-free survival and overall survival with and without renal impairment at the time of multiple myeloma diagnosis were compared, and prognostic indicators were analysed.ResultsSix studies were finally included. Among patients with multiple myeloma, 319 had renal impairment, and 1166 had no renal impairment. Compared to the control group, no significant difference was observed in overall or progression-free survival in patients with multiple myeloma complicated with renal impairment.ConclusionThe limited low-quality evidence available does not support an association between prognosis and multiple myeloma complicated by kidney injury.

引用

页数：9

共 42 条

[1]

Amaador K, 2019, NETH J MED, V77, P243

[2] Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR [J].

Avet-Loiseau, Herve ;

San-Miguel, Jesus ;

Casneuf, Tineke ;

Iida, Shinsuke ;

Lonial, Sagar ;

Usmani, Saad Z. ;

Spencer, Andrew ;

Moreau, Philippe ;

Plesner, Torben ;

Weisel, Katja ;

Ukropec, Jon ;

Chiu, Christopher ;

Trivedi, Sonali ;

Amin, Himal ;

Krevvata, Maria ;

Ramaswami, Priya ;

Qin, Xiang ;

Qi, Mia ;

Sun, Steven ;

Qi, Ming ;

Kobos, Rachel ;

Bahlis, Nizar J. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (10) :1139-+

[3] New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia [J].

Banaszkiewicz, Malgorzata ;

Malyszko, Jolanta ;

Vesole, David H. ;

Woziwodzka, Karolina ;

Jurczyszyn, Artur ;

Zorawski, Marcin ;

Krzanowski, Marcin ;

Malyszko, Jacek ;

Batko, Krzysztof ;

Kuzniewski, Marek ;

Krzanowska, Katarzyna .

JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)

[4] Management of acute kidney injury in symptomatic multiple myeloma [J].

Bridoux, Frank ;

Leung, Nelson ;

Belmouaz, Mohamed ;

Royal, Virginie ;

Ronco, Pierre ;

Nasr, Samih H. ;

Fermand, Jean Paul .

KIDNEY INTERNATIONAL, 2021, 99 (03) :570-580

[5] Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy [J].

Bridoux, Frank ;

Arnulf, Bertrand ;

Karlin, Lionel ;

Blin, Nicolas ;

Rabot, Nolwenn ;

Macro, Margaret ;

Audard, Vincent ;

Belhadj, Karim ;

Pegourie, Brigitte ;

Gobert, Pierre ;

Cornec Le Gall, Emilie ;

Joly, Bertrand ;

Karras, Alexandre ;

Jaccard, Arnaud ;

Augeul-Meunier, Karine ;

Manier, Salomon ;

Royer, Bruno ;

Caillot, Denis ;

Tiab, Mourad ;

Delbes, Sebastien ;

Suarez, Felipe ;

Vigneau, Cecile ;

Caillard, Sophie ;

Arakelyan-Laboure, Nina ;

Roos-Weil, Damien ;

Chevret, Sylvie ;

Fermand, Jean Paul .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (23) :2647-+

[6] Treatment and disease-related complications in multiple myeloma: Implications for survivorship [J].

Chakraborty, Rajshekhar ;

Majhail, Navneet S. .

AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) :672-690

[7] Incidence, prognostic impact and clinical outcomes of renal impairment in patients with multiple myeloma: a population-based registry [J].

Courant, Maxime ;

Orazio, Sebastien ;

Monnereau, Alain ;

Preterre, Julie ;

Combe, Christian ;

Rigothier, Claire .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (03) :482-490

[8] Diagnosis and Management of Multiple Myeloma A Review [J].

Cowan, Andrew J. ;

Green, Damian J. ;

Kwok, Mary ;

Lee, Sarah ;

Coffey, David G. ;

Holmberg, Leona A. ;

Tuazon, Sherilyn ;

Gopal, Ajay K. ;

Libby, Edward N. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (05) :464-477

[9] International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment [J].

Dimopoulos, Meletios A. ;

Sonneveld, Pieter ;

Leung, Nelson ;

Merlini, Giampaolo ;

Ludwig, Heinz ;

Kastritis, Efstathios ;

Goldschmidt, Hartmut ;

Joshua, Douglas ;

Orlowski, Robert Z. ;

Powles, Raymond ;

Vesole, David H. ;

Garderet, Laurent ;

Einsele, Hermann ;

Palumbo, Antonio ;

Cavo, Michele ;

Richardson, Paul G. ;

Moreau, Philippe ;

San Miguel, Jesus ;

Rajkumar, S. Vincent ;

Durie, Brian G. M. ;

Terpos, Evangelos .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) :1544-+

[10] Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment [J].

Dimopoulos, Meletios A. ;

Christoulas, Dimitrios ;

Roussou, Maria ;

Kastritis, Efstathios ;

Migkou, Magdalini ;

Gavriatopoulou, Maria ;

Matsouka, Charis ;

Mparmparoussi, Despoina ;

Psimenou, Erasmia ;

Grapsa, Irini ;

Efstathiou, Eleni ;

Terpos, Evangelos .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (01) :1-5

← 1 2 3 4 5 →